Filing Details
- Accession Number:
- 0001441844-11-000020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-02 15:08:51
- Reporting Period:
- 2011-06-01
- Filing Date:
- 2011-06-02
- Accepted Time:
- 2011-06-02 15:08:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 835887 | Progenics Pharmaceuticals Inc | PGNX | Pharmaceutical Preparations (2834) | 133379479 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1250274 | J Robert Israel | 777 Old Saw Mill River Road Tarrytown NY 10591 | Senior Vp Medical Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-06-01 | 1,000 | $5.33 | 45,040 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-06-01 | 1,000 | $8.15 | 44,040 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-06-01 | 1,000 | $0.00 | 1,000 | $5.33 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 38,000 | 2010-07-01 | 2019-07-01 | No | 4 | M | Direct |
Footnotes
- The Reporting Person is exercising options under this grant in pre-established increments under and in accordance with provisions of a previously established Plan of Sale under Rule 10b5-1, which was established in accordance with the policies and procedures of the Issuer.
- This transaction was executed in multiple trades at prices ranging from $8.06 to $8.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The stock options become exercisable in three equal installments, commencing one year from the grant date.
Billionaire Hedge Funds
